Icosapent Ethyl
Amarin Pharmaceutical
[]
#respect-epa at #aha2022: in open-label rct of 1.8g epa + statin vs statin alone in 2,460 patients w/ chronic cad and epa/aa &lt;0.4, ~22% in 1 composite outcome with p=0.05, small but signif risk of af consistent w/ prev fish oil studies 
Cardiologist + researcher @MGHHeartHealth. Preventive cardiology, women's health, pregnancy, health policy. Tweets are my own. He/him.